Skip to content

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03337269
Enrollment
256
Registered
2017-11-08
Start date
2017-03-01
Completion date
2018-02-15
Last updated
2018-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV-Related Cervical Carcinoma

Brief summary

This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an educational handout) and then a questionnaire will be administered to assess knowledge and acceptability of the HPV vaccine. Subject charts will be reviewed to assess for initiation of the HPV vaccine.

Interventions

OTHEREducational video

Approximately 7 minute video on the HPV vaccine

One page handout on the HPV vaccine

OTHERControl

Control

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
12 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

1. Females ages greater than or equal to 12 years and less than or equal to 26 years 2. Presenting to a gynecology clinic for a routine or problem visit 3. Ability to read and write

Exclusion criteria

1. Women ages less than or greater than 12 years or greater than 26 years 2. Women with known cervical cancer 3. Known pregnancy 4. Prior initiation or completion of the HPV vaccine series

Design outcomes

Primary

MeasureTime frameDescription
HPV vaccine acceptabilityUp to 6 monthsSubject reported willingness to accept the HPV vaccination, as assessed through agreement or disagreement to the statement I would be willing to accept the HPV vaccine today.

Secondary

MeasureTime frameDescription
HPV vaccine knowledgeUp to 6 monthsSubject knowledge of the HPV vaccine and its associated risks and benefits, as assessed through a survey. Subjects are asked to answer 7 questions and total knowledge score is calculated by an unweighted sum of correct answers.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026